REPROCELL invests in Histocell, S.L. a Spain-based CDMO
REPROCELL invests in Histocell, S.L. a Spain-based CDMO Yokohama Japan, 23 November 2022: REPROCELL Inc. decided to invest in Histocell S.L. to strengthen its clinical induced pluripotent stem cell (iPSC) service offerings. Histocell is a CDMO based in Bilbao, Spain, with an authorized Advanced Therapy Medical Product (ATMP) manufacturing facility that offers GMP-grade manufacturing services for…